{"name":"Institut de Recherche pour le Developpement","slug":"institut-de-recherche-pour-le-developpement","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Anti-HBV antiviral prophylaxis","genericName":"Anti-HBV antiviral prophylaxis","slug":"anti-hbv-antiviral-prophylaxis","indication":"Hepatitis B virus prophylaxis","status":"phase_3"},{"name":"Chloroquine profilaxis","genericName":"Chloroquine profilaxis","slug":"chloroquine-profilaxis","indication":"Malaria prophylaxis in endemic regions","status":"marketed"},{"name":"Gatifloxacin combined regimen","genericName":"Gatifloxacin combined regimen","slug":"gatifloxacin-combined-regimen","indication":"Bacterial infections (likely respiratory, urinary tract, or other systemic infections in a combined regimen context)","status":"phase_3"},{"name":"Nevirapine, zidovudine, lamivudine","genericName":"Nevirapine, zidovudine, lamivudine","slug":"nevirapine-zidovudine-lamivudine","indication":"HIV-1 infection","status":"phase_3"},{"name":"sulfadoxine-pyrimethamine / mefloquine","genericName":"sulfadoxine-pyrimethamine / mefloquine","slug":"sulfadoxine-pyrimethamine-mefloquine","indication":"Malaria treatment and prevention","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Creatinina","genericName":"Creatinina","slug":"creatinina","indication":"Other","status":"phase_2"},{"name":"Praziquantel 600 milligram","genericName":"Praziquantel 600 milligram","slug":"praziquantel-600-milligram","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Anti-HBV antiviral prophylaxis","genericName":"Anti-HBV antiviral prophylaxis","slug":"anti-hbv-antiviral-prophylaxis","phase":"phase_3","mechanism":"Anti-HBV antiviral prophylaxis prevents hepatitis B virus infection or reactivation by inhibiting viral replication through antiviral mechanisms.","indications":["Hepatitis B virus prophylaxis","Prevention of HBV reactivation in at-risk populations"],"catalyst":""},{"name":"Chloroquine profilaxis","genericName":"Chloroquine profilaxis","slug":"chloroquine-profilaxis","phase":"marketed","mechanism":"Chloroquine inhibits parasite growth by accumulating in parasite food vacuoles and interfering with heme detoxification and nucleic acid synthesis.","indications":["Malaria prophylaxis in endemic regions","Malaria treatment (Plasmodium vivax, P. ovale, P. malariae, and chloroquine-sensitive P. falciparum)"],"catalyst":""},{"name":"Creatinina","genericName":"Creatinina","slug":"creatinina","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Gatifloxacin combined regimen","genericName":"Gatifloxacin combined regimen","slug":"gatifloxacin-combined-regimen","phase":"phase_3","mechanism":"Gatifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription in susceptible microorganisms.","indications":["Bacterial infections (likely respiratory, urinary tract, or other systemic infections in a combined regimen context)"],"catalyst":""},{"name":"Nevirapine, zidovudine, lamivudine","genericName":"Nevirapine, zidovudine, lamivudine","slug":"nevirapine-zidovudine-lamivudine","phase":"phase_3","mechanism":"This combination of three antiretroviral drugs inhibits HIV reverse transcriptase and non-nucleoside reverse transcriptase to suppress viral replication.","indications":["HIV-1 infection"],"catalyst":""},{"name":"Praziquantel 600 milligram","genericName":"Praziquantel 600 milligram","slug":"praziquantel-600-milligram","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"sulfadoxine-pyrimethamine / mefloquine","genericName":"sulfadoxine-pyrimethamine / mefloquine","slug":"sulfadoxine-pyrimethamine-mefloquine","phase":"phase_3","mechanism":"Sulfadoxine-pyrimethamine is a combination of a sulfonamide antibiotic and a dihydrofolate reductase inhibitor, while mefloquine is a blood schizonticide.","indications":["Malaria treatment and prevention"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOdC1rd3RYS000Tm0yZmZvaFZfcEtKeTJWSkUzNGMwQW5ZM0NvY25RMUJ3emZoelNuZmFTZDU4QWVwLWNRN0xLZFBvaGRya3lTQlNkeGlOcnFlUlZNSXJkSnlqNzFuU1RoY19BQzdfUEowOHlDbk9KWTBESFd5N0xudUY5TkQtdGNtVU9Fd2ZSRHJldw?oc=5","date":"2025-08-27","type":"pipeline","source":"ici.radio-canada.ca","summary":"Des microdoses de lithium pour freiner l’alzheimer? - ici.radio-canada.ca","headline":"Des microdoses de lithium pour freiner l’alzheimer? - ici.radio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQbDVRYzZ0RWFvVktKcElDc28zYWpUZmpJejM3YndQdVFkLWlMVkhxUS1iNm53YlJYRDJSTE1LT0J2ZlNrelNaOGxrTmJ6czNPUkVVeG1PU0plQ2ZsTnQ0TVdVLW02WERXMzlwYkNmM3NvNENibHpJeUZLRVU4d0t6RzJpd3lZMl90QUQ5QkEtRWIwdXVqVVZsRnA2SQ?oc=5","date":"2025-05-22","type":"pipeline","source":"PublicEye.ch","summary":"«Pantouflage pharma»: Des organes de régulation suisses sous influence? - PublicEye.ch","headline":"«Pantouflage pharma»: Des organes de régulation suisses sous influence?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNQWRfbVEyUTVqazd6OGtQcjdFVld4MUpGY05rTy01S2dxM1JGQTFyaVRicnc2cGFFWXp3em1QMEdXNjcweTV0aGhXR19MSUd1ZHRMN0tybkQwVUlSTUFDQy13ZmhVMFB2Yzg2ZzNfS3J5NXRjUFFVRWZiVHk2UXpKcUcybXIzTkdHOWxlamQ0SW12WFF0TEFZRV83U3JYVUFtS2pVZV9uakcwblNxcE5IQWVSc09XeHRGSk9nZURQU0V3UQ?oc=5","date":"2025-05-16","type":"pipeline","source":"Département des Bouches-du-Rhône","summary":"Prix départemental pour la recherche en Provence - Département des Bouches-du-Rhône","headline":"Prix départemental pour la recherche en Provence - Département des Bouches-du-Rhône","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQbVFfc0l1RE9CSkduZ2p0RFcwUTRsZE9NWGl1Ukpqc0FpNmdIdW5HREtZSkVteUV6V2pISUxQWUVlVE9Ja1JMRWtOT3NJd0J2dHRGWlVLUGxNVDBpYVE2aENIX3NvUHFGaUpaMUFtYnZ4MmpiUW50RzJZRlZCdml1eDlWTjNWdUVIWGdsdGNyWExuM0xmeG5RR3pUOGZVTmw0dHV6MmdYNWNhbXExZEFsckstMGRJbVIyVlJieWVVUTVmcmU3M1Z1R05PRFB4cUU2aHFxaHBVdmFNZFFmVDJnUFNDM0xWNC1VdkpwdnYtUnpwZ3Vvd0Jlck13ZFE2Q05RVDRkbkxn?oc=5","date":"2024-09-19","type":"pipeline","source":"MyPharma Editions","summary":"Maladie de Huntington : HuntX Pharma lève 1,7 millions d’euros pour accélérer le développement préclinique et clinique de son candidat médicament - MyPharma Editions","headline":"Maladie de Huntington : HuntX Pharma lève 1,7 millions d’euros pour accélérer le développement préclinique et clinique d","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNakJNQ1d2OE12MTJ1Wk5QVzhDdVg2MkpaRGt4Y3N3SUo2Q21mYWVTZUgxdVFTNFNULWZ4SmNsVWZOem9WdHZCWExVcS1hMXZ6RUhKY29yR2RwV0lnYWF6cmhPal9YYzRVemtUMEc5czVwUlJsVGZ3czd3N2tlLXNZS3AyRWlqQlE3UkdENQ?oc=5","date":"2024-06-27","type":"pipeline","source":"Frontiers","summary":"Access to Medicines, Access to Markets - Frontiers","headline":"Access to Medicines, Access to Markets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxOTmw5LWkyVVhLLTRIZWVlQWQ2M2FqRmF3dFphMEtrQjk0WmhfN1luaElhck1PaFRUeUl4bnltYjVUdTh5c2VDS0FBTkMxbExxMEJySEdYUEttUXJGbXJxMGVIWDFCVkhzZExJTFZ4VVp3N2dCQzRWTndTT2luNzBmWVJpZXd2Qjg0X19WNmdzN1lzRnRlaEgwRVZGNk9iVUtNNE5mSlV1bENaSjVER2NqV1QwZERLdzQ0ZUNDRlg0ZEZONUlmaUVxbnB4RGQ2TmQ2bG9jVHdPV1Z4bk9HSVgzUGVVNXRLZkl5cVk3dE9rZWc0ZGE1azRBU2pPOUJJcVRsQzBUNA?oc=5","date":"2024-06-26","type":"pipeline","source":"SWI swissinfo.ch","summary":"Avec l’IA, les pharmas accélèrent la découverte de nouveaux médicaments - SWI swissinfo.ch","headline":"Avec l’IA, les pharmas accélèrent la découverte de nouveaux médicaments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPOENFRkQ2SlNfVF9FUE5Sckx5YXhSYmhNTmZFRVRLb3JRdDVPZHoxQnNzQ1c5LW1pMU9NMFNrcVllNnhkNFdpX29EczNncjU0NDYxSGRKeWlZakdINF9wdjBGQXIwSHYzRjU5VjNsdV9vMzRnc2VqSHdfeGZkLUVneTZrR2M2RldFTExvUlFHTkdtZE0tbEVoWVAwS3NwSlFWQm8zV3JGWFg1MF9OeTU1dFhSd19STklzeVg5SDdOTTRWcDNZejVDX1NDYXVzSmVhSFBZ?oc=5","date":"2022-10-07","type":"pipeline","source":"Blast Info","summary":"Comment la France s’est fait déposséder du médicament le plus cher au monde - Blast Info","headline":"Comment la France s’est fait déposséder du médicament le plus cher au monde","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPNnp3SXVlM2NlclR5RU5Yd2Z1YWVZb05OU2diTWVaWkpLQ3B0QV9jcFE1M01DaXE3UXN5UmdNZzQ1eUdRT0o0ZjgyazhtMlVvZm5kb1BoQmZuR0M1NXp0bHBTeXJHS2JJMTc1MUo5Wm9naGp2b1Vfd3BTQXdJQ2FxbTFndk5neE5SU09mVkhSRnUxUEhYejJyaUxrams4S01BWnFUMW5WdmdWajFha0p3Vm1zbkRvLWc?oc=5","date":"2021-02-23","type":"pipeline","source":"INRAE","summary":"INRAE, Institut responsable en matière d’expérimentation animale - INRAE","headline":"INRAE, Institut responsable en matière d’expérimentation animale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPS2NrUTNCQ3VFOE9DdDBScTdMcEZ3elpaWFNyUWRuTEx2eVB0RjBuc3EzYW9hRUdFRmxPbXlLa25ZMzdFUFVXcVZmQ1N0MHU2blh2V1JKWVpTcHFZU3FpRzlQcEV3WDlkbXNSWkVGcTBxeEt5WXM3WXY3S3VrVTM4anJpTUF4X19lcTh6bUdNR0NObWxtZWhkOGJKbDJ3MnBSWjh4ZU0xNlJUM1c0S2VEb3J0X00tMHNlNk43bkRkYmlPZlI3SlFEdldvTUV2WHRjOUh0OHduNmVuNzcwdkJNVFJaM1h5QQ?oc=5","date":"2020-10-06","type":"pipeline","source":"patrimoine24.com","summary":"Atland Voisin conclut un sale & lease back avec le groupe pharmaceutique et dermo-cosmetique Pierre Fabre - patrimoine24.com","headline":"Atland Voisin conclut un sale & lease back avec le groupe pharmaceutique et dermo-cosmetique Pierre Fabre - patrimoine24","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPX2NHcWJEVDlPQ2dZRXhtMDg4czM0Rkh1TDJGd0hzdGFZOWt4bEF6STFSdVRHT1BuMFNfeDdlQU15dGVwWS1JUVc3TXVBVnExXzFYZk1fMTlBLUg5NDNRVzE5cWtkNmJEZ1pBSWpGclhMWkJvZkEtd0ZhTWxKV0xpdlkwdlJVeVdSX3Q4czFJbDBrZk5TeFZzbDhLZlhEMW9TRzI1cjBLWGEtLXVEZHAzQ0lIeGN1Y2J2SWhJQXo2aFZERWtXY0h3NmdNRXZERkw0VlRTcnJyRV96Y1hqd3ZCRXZlUjVsWGo4X0U0?oc=5","date":"2020-04-08","type":"pipeline","source":"Le Monde.fr","summary":"« Non, l’Afrique n’est pas, ni de près ni de loin, la cible privilégiée des essais cliniques » - Le Monde.fr","headline":"« Non, l’Afrique n’est pas, ni de près ni de loin, la cible privilégiée des essais cliniques »","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPdlMyU0ZvZmQtcDY2ZDNISmhuWGRLQ09VeDliOVYxeDI0NEZNVlRUVWhJaHYwYm5YSVN2VVE1SDBRUFFsMmY0TS00aTRVcm5YeHQxQ3hWQUVzRUpxclRJbGFuLW5pV3ppLUZPaVUwZ3BBRUhJRzk1SkFzVkpPMkIzbTBjQ1hoMjJ4STZGbVdyWXh5RGpJNFNhYWVWQXVTSm5nMEFpakl4QVBnRWhoM3Z5dGE5LW5HTUlUQm5pczRR?oc=5","date":"2020-02-09","type":"pipeline","source":"rts.ch","summary":"Comment une piqûre pour soigner des bébés peut coûter 2 millions de francs - rts.ch","headline":"Comment une piqûre pour soigner des bébés peut coûter 2 millions de francs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9kVW1ZMU8zdHpYYWxRa1ZTbjBhUHdsNkhGc3M3NFZ4ODRtcEg3YVppd3pDX09FNGRTdWM1VHJERVN5X21vRTBnd0lTYjdjekR0MzROSWx6LWRmUkNEN3c?oc=5","date":"2015-06-17","type":"pipeline","source":"OpenEdition Journals","summary":"Médicaments génériques : pivot de la reconstruction de l’industrie pharmaceutique - OpenEdition Journals","headline":"Médicaments génériques : pivot de la reconstruction de l’industrie pharmaceutique","sentiment":"neutral"}],"patents":[],"drugCount":7,"phaseCounts":{"phase_3":4,"marketed":1,"phase_2":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}